Lu Chien-Yu, Kuo Fu-Chen, Wang Sheng-Wen, Lo Yi-Ching, Wu I-Chen, Chang Lin-Li, Yu Fang-Jung, Su Yu-Chung, Wang Wen-Ming, Jan Chang-Ming, Wu Deng-Chyang
Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City 807, Taiwan.
Diagn Microbiol Infect Dis. 2006 Nov;56(3):241-6. doi: 10.1016/j.diagmicrobio.2006.04.008. Epub 2006 Jun 6.
Noninvasive methods for assessing Helicobacter pylori infection status are now an integral part of managing patients with upper gastrointestinal complaints. The aim of this study is to evaluate the feasibility and diagnostic accuracy of 2 rapid tests: a urine-based H. pylori antibody detection method (Rapirun) and a stool-based H. pylori antigen detection method (immunocard STAT! HpSA). The combined use of the mentioned 2 tests was also evaluated, which has not been described in previous similar studies. Urine and stool specimens were collected from patients who were arranged for gastroendoscopic examination. The urine and stool specimens were tested with Rapirun and immunocard STAT! HpSA separately. The estimated reaction time was about 15 to 20 min for the former and 5 to 10 min for the latter. H. pylori infection was confirmed with 4 tests: culture, histology, rapid urease test, and the (13)C-urea breath test. Obtained results from both kits were compared with confirmed results. One hundred twenty patients were eligible for analysis. Of them, 62 tested positive for H. pylori infection and 58 were negative by the confirmation criteria. The urine Rapirun test relative to the confirmed results showed sensitivity, specificity, and accuracy as 87.1% (confidence interval [CI] = 81.1-93.1%), 89.7% (CI = 84.2-95.1%), and 88.3%, respectively. The stool immunocard STAT! HpSA test relative to the confirmed results showed sensitivity, specificity, and accuracy as 96.8% (CI = 93.6-99.9%), 82.8% (CI = 76.0-89.5%), and 90%, respectively. The combined-use method of both tests revealed sensitivity, specificity, and accuracy as 98.4% (CI = 96.1-100%), 81.0% (CI = 74.0-88.1%), and 90%, respectively. These 2 urine and stool tests have a satisfactory accuracy around 90% in detecting H. pylori infection. In consideration of the advantages of cheapness, timesaving, and ease of use, both can be used as rapid near-patient tests in general practice. The combined use of both tests was also promising in detecting H. pylori infection.
评估幽门螺杆菌感染状况的非侵入性方法现已成为管理上消化道疾病患者的重要组成部分。本研究的目的是评估两种快速检测方法的可行性和诊断准确性:一种基于尿液的幽门螺杆菌抗体检测方法(Rapirun)和一种基于粪便的幽门螺杆菌抗原检测方法(免疫卡STAT! HpSA)。还评估了上述两种检测方法的联合使用情况,此前类似研究中尚未对此进行描述。从安排进行胃镜检查的患者中采集尿液和粪便样本。尿液和粪便样本分别用Rapirun和免疫卡STAT! HpSA进行检测。前者的估计反应时间约为15至20分钟,后者为5至10分钟。通过四种检测方法确认幽门螺杆菌感染:培养、组织学、快速尿素酶试验和(13)C尿素呼气试验。将两种试剂盒获得的结果与确认结果进行比较。120名患者符合分析条件。其中,62例幽门螺杆菌感染检测呈阳性,58例根据确认标准为阴性。相对于确认结果,尿液Rapirun检测的敏感性、特异性和准确性分别为87.1%(置信区间[CI]=81.1 - 93.1%)、89.7%(CI = 84.2 - 95.1%)和88.3%。粪便免疫卡STAT! HpSA检测相对于确认结果的敏感性、特异性和准确性分别为96.8%(CI = 93.6 - 99.9%)、82.8%(CI = 76.0 - 89.5%)和90%。两种检测方法的联合使用显示敏感性、特异性和准确性分别为98.4%(CI = 96.1 - 100%)、81.0%(CI = 74.0 - 88.1%)和90%。这两种尿液和粪便检测方法在检测幽门螺杆菌感染方面的准确性约为90%,令人满意。考虑到价格便宜、节省时间和使用方便等优点,两者均可在全科医疗中用作快速即时检测。两种检测方法的联合使用在检测幽门螺杆菌感染方面也很有前景。